Summary. Aspirin and indomethacin, inhibitors of prostaglandin biosynthesis, were utilized to determine the role of prostaglandins (PGs) in ovarian weight gain in rats following unilateral ovariectomy or treatment with PMSG. After unilateral ovariectomy, the compensatory ovarian hypertrophy was 185\m=.\0%compared with 139\m=.\8% and 97\m=.\5% in rats treated with indomethacin and aspirin, respectively. The adrenal weights in rats treated with aspirin were also reduced significantly. Administration of PGE2 or PGF2\g=a\ with aspirin reversed the effect of aspirin on the adrenals but had no effect on the ovarian weight. Indomethacin and aspirin treatment of animals injected with PMSG also reduced the ovarian weight gain. If 100 \g=m\gPGE2 were given twice daily, this effect was reversed in both groups but thrice daily administration had no effect on rats receiving aspirin. In PMSG-treated rats, 100 \ g=m\ g PGF2\g=a\ twice daily did not reverse the effect of indomethacin and aspirin, and actually enhanced the effect of aspirin.
INTRODUCTION
Compensatory ovarian hypertrophy is thought to result from the hypersecretion of pituitary gonadotrophins following the removal of one ovary (Benson et al., 1969) . Recently, the inhibition of compensatory ovarian hypertrophy in the rat was reported in association with the dietary ingestion of aspirin (Goldman & Poppens, 1972) ; this was a toxicological observation only and no effort was made to elucidate the mechanism of inhibition. Since aspirin is known to inhibit prostaglandin (PG) synthesis (Flower, 1974) , it was of interest to us to determine whether PGs might be involved in ovarian hypertrophy in response to endogenous or exogenous gonadotrophic stimulation. Aspirin and indomethacin were used to determine the role of PGs in ovarian weight gain following unilateral ovariectomy or treatment with PMSG. In both of these studies, attempts were made to reverse the inhibition of aspirin and indomethacin by the concomitant administration of either PGE2 or PGF2\g=a\. (Duncan, 1957) .
RESULTS

Compensatory ovarian hypertrophy
The final mean ovarian weight of untreated control animals showed a 185-0% increase above the initial weight over the 2-week period ( , although the possible involvement in the control of the LH surge is still equivocal (see Labhsetwar, 1974 (Labhsetwar, 1974) . Preliminary studies suggest a possible role for PGs in the process of luteinization (Ellsworth & Armstrong, 1974; Labhsetwar, 1974) , although Grinwich et al. (1972) found normal luteinization in rabbits in which ovulation was inhibited. The increase in ovarian PG production following gonadotrophin stimulation (Chasalow & Pharriss, 1972; Wilks et al., 1972) , the mimicking of ovarian biochemical events which are initiated by gonado¬ trophins (Perklev & Ahren, 1971 ; Lamprecht et al., 1973; Tsafriri et al., 1973; Kuehl, 1974) , and the presence of PG receptors in CL (Rao, 1973) suggest an important physiological role for this class of compounds in ovarian regulation. Kuehl (1974) (Cooper, 1974) (Goldman & Poppens, 1972) , the daily intake was calculated to range from 9 to 13 mg daily, and thus the present 2-week period of the compensatory ovarian hypertrophy experi¬ ment was probably associated with a greater toxic effect than the 1 week of the PMSG experiment. The inability of either PGE2 or PGF2(Z to reverse the effect of aspirin in the compensatory ovarian hypertrophy experiment, there¬ fore, may be related to the toxic levels used. In the PMSG experiment, it is significant that PGE2, but not PGF2tI was capable of reversing the inhibition since the E series of PGs seem to be most essential in the ovarian response to LH stimulation Lamprecht et al., 1973; Kuehl, 1974; Labhsetwar, 1974) , whereas PGF2ct, which was not effective in this experiments, is the most effective luteolytic PG in the rat (Labhsetwar, 1974) . A luteolytic effect can also be obtained with PGE2 in the rat, but only with higher doses than those required for PGF2it (Labhsetwar, 1974) (Flack et al., 1969) and PGEs have been reported to increase steroid production by beef adrenal slices (Saruta & Kaplan, 1972) . More relevant to the present study is the report that indomethacin reduced the adrenal response of hypophysectomized rats to ACTH, which could be res¬ tored with PGE2 treatment (Gallant & Brownie, 1973 ). An alternative possi¬ bility is an effect on ACTH release, which is very sensitive to the effect of PGs ; as little as 0-25^g PGEJ100 g body wt intravenously is capable of causing a significant increase in serum ACTH (Hedge, 1972) . The use of the PG analogue, 7-oxo-13-prostynoic acid, also decreased the release of ACTH by rat hemipituitaries incubated in vitro (Vale et al., 1971) . The exact role of PGs in adrenal regulation requires further experimental work.
